4.4 Article

Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Journal

EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
Volume 18, Issue 7, Pages 534-544

Publisher

OXFORD UNIV PRESS
DOI: 10.1177/1474515119856207

Keywords

Risk prediction; risk assessment; cardiovascular disease; prevention; patient

Ask authors/readers for more resources

Risk assessment have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury

Matthieu Leuillier, Thomas Duflot, Severine Menoret, Hind Messaoudi, Zoubir Djerada, Deborah Groussard, Raphael G. P. Denis, Laurence Chevalier, Ahmed Karoui, Baptiste Panthu, Pierre-Alain Thiebaut, Isabelle Schmitz-Afonso, Severine Nobis, Cynthia Campart, Tiphaine Henry, Camille Sautreuil, Serge H. Luquet, Olivia Beseme, Catherine Feliu, Helene Peyret, Lionel Nicol, Jean-Paul Henry, Sylvanie Renet, Paul Mulder, Debin Wan, Laurent Tesson, Jean-Marie Heslan, Angeline Duche, Sebastien Jacques, Frederic Ziegler, Valery Brunel, Gilles J. P. Rautureau, Christelle Monteil, Jean-Luc do Rego, Jean-Claude do Rego, Carlos Afonso, Bruce Hammock, Anne-Marie Madec, Florence Pinet, Vincent Richard, Ignacio Anegon, Christophe Guignabert, Christophe Morisseau, Jeremy Bellien

Summary: The physiological role of the N-terminal phosphatase activity (sEH-P) of soluble epoxide hydrolase (sEH-H) was investigated using CRISPR/Cas9 to generate a knock-in (KI) rat line lacking sEH-P activity. The study found that sEH-P KI rats exhibited decreased metabolism of lysophosphatidic acids, decreased weight and fat mass gain, and increased insulin sensitivity. Moreover, sEH-P KI rats showed increased lipolysis and enhanced energy expenditure, which potentiated brown adipose thermogenesis. Additionally, sEH-P KI rats fed a high-fat diet did not experience weight gain, fat mass accumulation, insulin resistance, or hepatic steatosis, and they also exhibited enhanced cardiac mitochondrial activity and protection against ischemia-reperfusion injury. Overall, the findings highlight the importance of sEH-P in energy and fat metabolism and its potential therapeutic significance in the management of obesity and cardiac complications.

JOURNAL OF ADVANCED RESEARCH (2023)

Article Cell Biology

Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

Sol Beccari, Virginia Sierra-Torre, Jorge Valero, Marta Pereira-Iglesias, Mikel Garcia-Zaballa, Federico N. Soria, Laura De Las Heras-garcia, Alejandro Carretero-Guillen, Estibaliz Capetillo-Zarate, Maria Domercq, Paloma R. Huguet, David Ramonet, Ahmed Osman, Wei Han, Cecilia Dominguez, Travis E. Faust, Omar Touzani, Olatz Pampliega, Patricia Boya, Dorothy Schafer, Guillermo Marino, Emmanuelle Canet-Soulas, Klas Blomgren, Ainhoa Plaza-Zabala, Amanda Sierra

Summary: The dysfunction of microglial phagocytosis, resulting in impaired engulfment and degradation, is found in stroke and other brain disorders. This dysfunction is not explained by transcriptional changes but is related to energy depletion triggered by oxygen and nutrient deprivation. Modulating microglial autophagy may be a potential therapeutic strategy for stroke and other brain disorders.

AUTOPHAGY (2023)

Article Clinical Neurology

Sex differences in imaging and clinical characteristics of patients from the WAKE--UP trial

Anke Wouters, Lauranne Scheldeman, Hannelore Liessens, Patrick Dupont, Florent Boutitie, Bastian Cheng, Martin Ebinger, Matthias Endres, Jochen B. Fiebach, Christian Gerloff, Keith W. Muir, Norbert Nighoghossian, Salvador Pedraza, Claus Z. Simonsen, Vincent Thijs, Goetz Thomalla, Robin Lemmens

Summary: This study aimed to explore the sex-based differences in acute ischemic stroke within the WAKE-UP trial. It was found that women, compared to men, were older, had higher baseline NIHSS scores, and smoked less frequently. However, the treatment effect of alteplase on mRS scores was not modified by sex.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Editorial comments: focus on arterial hypertension and co-morbidities

Geza Halasz, Gianfranco Parati, Massimo F. Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines

Caterina Mas-Llado, Maribel Gonzalez-Del-Hoyo, Joan Siquier-Padilla, Laura Blaya-Pena, J. J. Coughlan, Bernardo Garcia de la Villa, Vicente Peral, Xavier Rossello

Summary: This study critically appraised the representativeness and standard of care of randomised clinical trials (RCTs) supporting clinical practice guidelines (CPGs) for acute coronary syndrome (ACS). The findings showed that RCTs are not fully representative of the diversity of ACS population and their current standard of care.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison

Sebastian Ludwig, Lenard J. Conradi, David J. Cohen, Augustin Coisne, Andrea Scotti, William Abraham, Walid Ben Ali, Zhipeng Zhou, Yanru Li, Saibal Kar, Alison Duncan, D. Scott Lim, Marianna Adamo, Bjoern Redfors, David W. M. Muller, John G. Webb, Anna S. Petronio, Hendrik Ruge, Georg Nickenig, Lars Sondergaard, Matti Adam, Damiano Regazzoli, Andrea Garatti, Tobias Schmidt, Martin Andreas, Gry Dahle, Thomas Walther, Joerg Kempfert, Gilbert H. L. Tang, Simon Redwood, Maurizio Taramasso, Fabien Praz, Neil Fam, Nicolas Dumonteil, Jean-Francois Obadia, Ralph Stephan von Bardeleben, Tanja K. Rudolph, Michael J. Reardon, Marco Metra, Paolo Denti, Michael J. Mack, Joerg Hausleiter, Federico M. Asch, Azeem Latib, JoAnn Lindenfeld, Thomas Modine, Gregg W. Stone, Juan F. Granada

Summary: This study compared the clinical outcomes of patients with secondary mitral regurgitation undergoing transcatheter mitral valve replacement (TMVR) versus guideline-directed medical therapy (GDMT). The results showed that TMVR reduced mitral regurgitation, decreased heart failure hospitalizations, and improved symptoms compared to GDMT. However, the two treatments had similar mortality rates over a 2-year follow-up period.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

Article Cardiac & Cardiovascular Systems

Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock after acute myocardial infarction: Insights from a French nationwide database

Matteo Pozzi, Cecile Payet, Stephanie Polazzi, Aubane L'Hospital, Jean Francois Obadia, Antoine Duclos

Summary: This study aimed to analyze the impact of timing of implantation and volume of procedures on survival of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for cardiogenic shock complicating acute myocardial infarction. Through a retrospective observational study using a nationwide database, patients were classified into early or delayed implantation groups and low or high-volume groups. The results showed no significant difference in 90-day mortality between the early and delayed implantation groups, as well as between high-volume and low-volume centers.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Article Multidisciplinary Sciences

Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease

Mathilde Prezelin-Reydit, Christian Combe, Denis Fouque, Luc Frimat, Christian Jacquelinet, Maurice Laville, Ziad Massy, Celine Lange, Carole Ayav, Roberto Pecoits-Filho, Sophie Liabeuf, Benedicte Stengel, Jerome Harambat, Karen Leffondre

Summary: We examined the correlation between uric acid levels and the risk of kidney failure and death in patients with chronic kidney disease (CKD). Higher uric acid levels above 10 mg/dl indicated an increased risk of kidney failure and death, while lower levels below 5 mg/dl were associated with death before kidney failure. These findings suggest that uric acid levels can serve as a potential marker for assessing the risk of adverse outcomes in CKD patients.

SCIENTIFIC REPORTS (2023)

Editorial Material Cardiac & Cardiovascular Systems

Focus on sport cardiology and exercise

Geza Halasz, Francesco Bandera, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Critical Care Medicine

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3)

Jean Reignier, Gaetan Plantefeve, Jean-Paul Mira, Laurent Argaud, Pierre Asfar, Nadia Aissaoui, Julio Badie, Nicolae-Vlad Botoc, Laurent Brisard, Hoang-Nam Bui, Delphine Chatellier, Louis Chauvelot, Alain Combes, Christophe Cracco, Michael Darmon, Vincent Das, Matthieu Debarre, Agathe Delbove, Jerome Devaquet, Louis-Marie Dumont, Olivier Gontier, Samuel Groyer, Laurent Guerin, Bertrand Guidet, Yannick Hourmant, Samir Jaber, Fabien Lambiotte, Christophe Leroy, Philippe Letocart, Benjamin Madeux, Julien Maizel, Olivier Martinet, Frederic Martino, Virginie Maxime, Emmanuelle Mercier, Mai-Anh Nay, Saad Nseir, Johanna Oziel, Walter Picard, Gael Piton, Jean-Pierre Quenot, Florian Reizine, Anne Renault, Jack Richecoeur, Jean-Philippe Rigaud, Francis Schneider, Daniel Silva, Michel Sirodot, Bertrand Souweine, Fabienne Tamion, Nicolas Terzi, Didier Thevenin, Guillaume Thiery, Nathalie Thieulot-Rolin, Jean-Francois Timsit, Francois Tinturier, Patrice Tirot, Thierry Vanderlinden, Isabelle Vinatier, Christophe Vinsonneau, Sebastian Voicu, Jean-Baptiste Lascarrou, Amelie Le Gouge

Summary: This study investigated the optimal calorie and protein intake for acute phase of severe critical illness. The results showed that early restriction of calorie and protein intake can accelerate recovery and reduce complications, but it does not have a significant impact on mortality compared to standard targets.

LANCET RESPIRATORY MEDICINE (2023)

Editorial Material Nutrition & Dietetics

Editorial: Women in nutrition and metabolism

Clare M. M. Reynolds, Teodora Handjieva-Darlenska, Julie-Anne Nazare

FRONTIERS IN NUTRITION (2023)

Review Cardiac & Cardiovascular Systems

Risk and Management of Patients with Cancer and Heart Disease

Loreena Hill, Bruno Delgado, Ekaterini Lambrinou, Tara Mannion, Mark Harbinson, Claire McCune

Summary: Cancer and cardiovascular disease are major causes of global mortality and morbidity. While medical research has advanced lifesaving cancer treatments, some of these treatments may have detrimental effects on the heart, leading to heart failure. Anthracycline therapy, a type of anti-cancer drug, can significantly impact patients' functional capacity, mental well-being, and quality of life. Recognizing this, recent guidelines and papers have provided recommendations for risk stratification and care delivery, including cardio-oncology services. This review will summarize the key evidence on anthracycline therapy and provide clinical guidance for non-oncology professionals caring for cancer patients with heart failure.

CARDIOLOGY AND THERAPY (2023)

Article Biochemistry & Molecular Biology

Adipokines in obesity and metabolic-related-diseases

Julien Pestel, Ferdinand Blangero, Julia Watson, Luciano Pirola, Assia Eljaafari

Summary: The discovery of leptin in the 1990s challenged the traditional view of adipose tissue as solely a storage organ and established it as an endocrine tissue capable of secreting bioactive molecules called adipokines and batokines. These molecules enable communication between adipose tissue and various organs, including the brain, heart, liver, pancreas, and vascular system. The balance between pro-inflammatory and anti-inflammatory adipokines is crucial for maintaining homeostasis in tissues and organs. Obesity disrupts this balance, leading to increased secretion of pro-inflammatory adipokines and contributing to local and systemic inflammation and associated comorbidities.

BIOCHIMIE (2023)

Article Biochemistry & Molecular Biology

MICU1 controls the sensitivity of the mitochondrial Ca2+uniporter to activators and inhibitors

Macarena Rodriguez-Prados, Kai-Ting Huang, Katalin Marta, Melanie Paillard, Gyorgy Csordas, Suresh K. Joseph, Gyorgy Hajnoczky

Summary: Mitochondrial Ca2+ homeostasis is dysregulated in many diseases and can be targeted therapeutically. The uniporter channel (mtCU), comprised of MCU and regulated by MICU1, plays a crucial role in mitochondrial Ca2+ uptake. Understanding the molecular mechanisms of mtCU activators and inhibitors is essential for developing effective therapies.

CELL CHEMICAL BIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Diferencias regionales en la atencion al IAMCEST en Espana. Datos del Registro de Codigo Infarto ACI-SEC

Oriol Rodriguez-Leor, Ana Belen Cid-Alvarez, Raul Moreno, Xavier Rossello, Soledad Ojeda, Ana Serrador, Ramon Lopez-Palop, Javier Martin-Moreiras, Jose Ramon Rumoroso, Angel Cequier, Borja Ibanez, Ignacio Cruz-Gonzalez, Rafael Romaguera, Sergio Raposeiras, Armando Perez de Prado

Summary: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality.

REC-INTERVENTIONAL CARDIOLOGY (2023)

No Data Available